IL164654A0 - Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists - Google Patents

Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists

Info

Publication number
IL164654A0
IL164654A0 IL16465404A IL16465404A IL164654A0 IL 164654 A0 IL164654 A0 IL 164654A0 IL 16465404 A IL16465404 A IL 16465404A IL 16465404 A IL16465404 A IL 16465404A IL 164654 A0 IL164654 A0 IL 164654A0
Authority
IL
Israel
Prior art keywords
combating
compositions
methods
receptor agonists
urinary tract
Prior art date
Application number
IL16465404A
Other languages
English (en)
Original Assignee
Ardent Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardent Pharmaceuticals Inc filed Critical Ardent Pharmaceuticals Inc
Publication of IL164654A0 publication Critical patent/IL164654A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16465404A 2002-05-09 2004-10-18 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists IL164654A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37918602P 2002-05-09 2002-05-09
US10/434,004 US8476280B2 (en) 2002-05-09 2003-05-08 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
PCT/US2003/014730 WO2003094853A2 (en) 2002-05-09 2003-05-09 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists

Publications (1)

Publication Number Publication Date
IL164654A0 true IL164654A0 (en) 2005-12-18

Family

ID=29423661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16465404A IL164654A0 (en) 2002-05-09 2004-10-18 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists

Country Status (11)

Country Link
US (1) US8476280B2 (es)
EP (1) EP1501513B1 (es)
JP (1) JP4637571B2 (es)
CN (1) CN100508980C (es)
AU (1) AU2003228991B8 (es)
CA (1) CA2525373C (es)
IL (1) IL164654A0 (es)
MX (1) MXPA04010934A (es)
NZ (1) NZ536352A (es)
RU (1) RU2333209C9 (es)
WO (1) WO2003094853A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60230869D1 (de) 2001-05-18 2009-03-05 Astrazeneca Ab 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
JP2005513080A (ja) * 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
WO2004060322A2 (en) * 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
US20050283385A1 (en) * 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
DK1781631T3 (da) 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
ES2283220B1 (es) * 2006-04-12 2008-11-01 Consejo Superior Investig. Cientificas Uso de agonistas del receptor opioide delta en la elaboracion de composiciones farmaceuticas, composiciones farmaceuticas que las contienen y sus aplicaciones en el tratamiento de tumores.
KR101288781B1 (ko) 2006-06-28 2013-07-22 암젠 인크 글리신 수송자-1 억제제
EP2104489A2 (en) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topical administration of danazol
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
KR102094626B1 (ko) * 2016-02-25 2020-03-27 히사미쓰 세이야꾸 가부시키가이샤 외용 액제

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5807858A (en) 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5985880A (en) 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US20020052007A1 (en) 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
ES2149881T3 (es) 1993-07-30 2000-11-16 Delta Pharmaceuticals Inc Compuestos de piperazina usados en terapia.
US6046200A (en) 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
JP2000515525A (ja) * 1996-07-19 2000-11-21 アベーグ，グンナー 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
US6090856A (en) * 1997-04-11 2000-07-18 Nippon Shinyaku Co., Ltd. Remedies for frequent urination and urinary incontinence
GB9804734D0 (en) 1998-03-05 1998-04-29 Pfizer Ltd Compounds
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0001207D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
DE10059415A1 (de) 2000-11-30 2002-06-06 Gruenenthal Gmbh Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz
RU2314809C2 (ru) 2001-10-29 2008-01-20 Маунт Кук Байосайенсиз, Инк. Способ лечения депрессии соединениями-агонистами дельта-рецепторов
WO2003057223A1 (en) 2002-01-02 2003-07-17 Ardent Pharmaceuticals, Inc. Method of treating sexual dysfunctions with delta opioid receptor agonist compounds

Also Published As

Publication number Publication date
RU2333209C2 (ru) 2008-09-10
RU2004133054A (ru) 2005-08-10
AU2003228991B2 (en) 2007-12-06
MXPA04010934A (es) 2005-02-14
CN100508980C (zh) 2009-07-08
WO2003094853A3 (en) 2004-08-19
RU2333209C9 (ru) 2009-01-20
EP1501513B1 (en) 2014-04-16
JP4637571B2 (ja) 2011-02-23
EP1501513A2 (en) 2005-02-02
NZ536352A (en) 2008-07-31
CA2525373C (en) 2012-04-24
EP1501513A4 (en) 2009-08-26
CA2525373A1 (en) 2003-11-20
AU2003228991A1 (en) 2003-11-11
AU2003228991B8 (en) 2009-07-02
US8476280B2 (en) 2013-07-02
US20040002503A1 (en) 2004-01-01
JP2005525416A (ja) 2005-08-25
CN1652787A (zh) 2005-08-10
WO2003094853A2 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
IL164654A0 (en) Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
HUP0401191A3 (en) Opioid agonist formulations with releasable and sequestered antagonist and process for their preparation
IL179380A0 (en) Compositions comprising nicotinic and opioid agonists
AU2003303142A8 (en) Multimedia content delivery through wlan coverage area
EP1588142A4 (en) METHOD FOR DIAGNOSIS OF RCC AND OTHER SOLID TUMORS
EP1718282A4 (en) PROCESS AND COMPOSITIONS FOR IMAGE PRESENTATION
ZA200701044B (en) Compositions for delivering peptide YY and PYY agonists
EP1809294A4 (en) COMPOUNDS AGAINST INFLAMMATION AND IMMUNE-RELEVANT USES
EP1482895A4 (en) AMINO ALKYL PHOSPHONATES AND RELATED COMPOUNDS AS EDG RECEPTOR AGONISTS
IL179999A (en) Preparations containing nebibolol and angiotensin receptor II antagonist and their uses
EP1804943A4 (en) DEVICES AND METHODS FOR CHARACTERISTIC BINGO BALL
RS50787B2 (sr) Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergične agoniste
EP1830824A4 (en) NANOTEIL COMPOSITION AND METHOD FOR THEIR SYNTHESIS
EP1797871A4 (en) LONG-TERM FORMULATION WITH DELAYED RELEASE WITH A DOPAMINE RECEPTOR AGONIST AND METHOD OF MANUFACTURING THEREOF
HK1073464A1 (en) Pyridinoylpiperidines as 5-ht1f agonists
GB0519316D0 (en) "Method and apparatus"
GB0518998D0 (en) "Measurement apparatus and method"
PL2319308T3 (pl) Grzybobójcza kombinacja substancji czynnych zawierająca fluoksastrobinę i inny środek grzybobójczy
EP1482896A4 (en) AMINOALKYLPHOSPHONATES AND ASSOCIATED COMPOUNDS AS EDG RECEPTOR AGONISTS
IL173621A0 (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
EP1808446A4 (en) IL-18 RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION WITH THE ANTAGONIST
EP1453503A4 (en) EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS
AU2002335089A1 (en) Apparatus for detecting estrus in livestock
TWI340740B (en) Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
EP1719792A4 (en) NETWORKED POLYIMIDE COMPOUND AND USE THEREOF